Featured Research

from universities, journals, and other organizations

Workers do not quit due to mandatory flu shot

Date:
June 11, 2013
Source:
Loyola University Health System
Summary:
In its fourth year with 99 percent compliance, Loyola University Health System's mandatory flu shot program is the subject of a new study presented at an infectious disease conference.

Mandatory influenza (flu) vaccination, as a condition of employment, does not lead to excessive voluntary termination, according to a four-year analysis of vaccination rates at Loyola University Health System in Chicago.

"First do no harm is our mandate as health care workers," said Jorge Parada, MD, MPH, FACP, FIDSA, study author and professor of medicine at Loyola University Chicago Stritch School of Medicine. "We have a fiduciary responsibility to perform hand hygiene and adhere to contact precautions, and flu vaccines should be considered in the same vein -- meaning we should do all we can to not pass along illness to our patients." Loyola has sustained a 99 percent compliance average since adopting the mandatory flu vaccination protocol four years ago.

Flu infections result in approximately 150,000 hospital admissions and 24,000 deaths annually. The Centers for Disease Control and Prevention (CDC) recommends that all healthcare personnel receive the annual flu vaccine, yet the national average for vaccination of health care professionals is only 64 percent.

"Just as construction workers must wear steel-toed boots and hard hats on job sites as a condition of employment, we believe that healthcare workers should get a flu shot to work in a hospital," said Parada, who leads the vaccination program at Loyola.

Infection prevention specialists worked with a multidisciplinary task force at Loyola to develop a facility-wide policy that made flu vaccination a condition of employment. Parada presented his study of the four-year program on June 9, 2013 at the annual conference of the Association for Professionals in Infection Control and Epidemiology.

As one of the first medical centers in the country to implement mandatory flu vaccination, Loyola began with the full backing of the hospital's senior leadership. "Starting in 2008, staff were no longer simply not allowed to not bother to get influenza vaccination, instead they were required by employee health to state "yes" or "no" when asked to be vaccinated and provide reasoning for why they declined the vaccine," said Parada. This delineation brought Loyola's overall vaccination rate up to 72 percent, well above the CDC's goal of more than 60 percent of health care professionals vaccinated. "This was still well short of what we at Loyola felt we should achieve to maximize patient safety," said Parada. "After all, this still meant more than one in four staff were not being immunized."

In 2009 Loyola chose to mandate flu vaccination as a condition of employment, and extended this mandate to students, volunteers, and vendors. To support and encourage compliance, the center's communications department developed facility-wide reminder emails and created short videos, which were displayed on flat screens throughout the hospital.

In the first year of their mandatory policy (2009/10 season), 99.2 percent of employees received the vaccine, 0.7 percent were exempted for religious/medical reasons, and 0.1 percent refused vaccination and chose to terminate employment. In 2012, four years later, the results have been sustained: 98.7 percent were vaccinated, 1.2 percent were exempted and 0.06 percent refused vaccination. "In reality our numbers were even better than that, of the 5 persons who refused vaccination in the mandatory period, 3 were unpaid volunteers, who later reconsidered, received vaccine and returned to Loyola. The two other persons were part-time staff, each with only 10% time commitment at Loyola…truly reflecting a 0.002 vaccine refusal rate" reports Parada. Over the course of four years, less than 15 staff, including volunteers, out of approximately 8,000 total chose termination over vaccination.

"Near universal flu immunization is achievable and sustainable with a mandatory vaccination policy," said Parada. "Our employees and associates now understand that this is the way Loyola does business and we believe that patient safety has been enhanced as a result."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Workers do not quit due to mandatory flu shot." ScienceDaily. ScienceDaily, 11 June 2013. <www.sciencedaily.com/releases/2013/06/130611154039.htm>.
Loyola University Health System. (2013, June 11). Workers do not quit due to mandatory flu shot. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/06/130611154039.htm
Loyola University Health System. "Workers do not quit due to mandatory flu shot." ScienceDaily. www.sciencedaily.com/releases/2013/06/130611154039.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins